Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 14;58(8):1101.
doi: 10.3390/medicina58081101.

Does Multisystem Inflammatory Syndrome Only Mimic Acute Appendicitis in Children or Can It Coexist: When Should We Suspect MIS-C?

Affiliations

Does Multisystem Inflammatory Syndrome Only Mimic Acute Appendicitis in Children or Can It Coexist: When Should We Suspect MIS-C?

Idilė Vansevičienė et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Acute abdominal pain in children has been noticed to be a primary reason to seek medical attention in multisystem inflammatory disorder (MIS-C), which can prevail separately or together with acute appendicitis. Our aim was to distinguish regular appendicitis cases from MIS-C and to suggest the best clinical and laboratory criteria for it. Materials and methods: Cases of patients, admitted to the Pediatric Surgery Department over a six-month period in 2021, were retrospectively analyzed. Confirmed MIS-C or acute appendicitis cases were selected. MIS-C cases were either separate/with no found inflammation in the appendix or together with acute appendicitis. Acute appendicitis cases were either regular cases or with a positive COVID-19 test. Four groups were formed and compared: A-acute appendicitis, B-MIS-C with acute appendicitis, C-MIS-C only and D-acute appendicitis with COVID-19. Results: A total of 76 cases were overall analyzed: A-36, B-6, C-29 and D-5. The most significant differences were found in duration of disease A—1.4 days, B—4.5 days, C—4 days, D—4 days (p < 0.0001), C reactive protein (CRP) values A-19.3 mg/L B-112.5 m/L, C-143.8 mg/L and D-141 mg/L (p < 0.0001), presence of febrile fever A-13.9%, B-66.7%, C-96.6% and D-40% (p < 0.0001) and other system involvement: A 0%, B 100%, C 100% and D 20%. A combination of these factors was entered into a ROC curve and was found to have a possibility to predict MIS-C in our analyzed cases (with or without acute appendicitis) with an AUC = 0.983, p < 0.0001, sensitivity of 94.3% and specificity of 92.7% when at least three criteria were met. Conclusions: MIS-C could be suspected even when clinical data and performed tests suggest acute appendicitis especially when at least three out of four signs are present: CRP > 55.8 mg, symptoms last 3 days or longer, febrile fever is present, and any kind of other system involvement is noticed, especially with a known prior recent COVID-19 contact, infection or a positive COVID-19 antibody IgG test.

Keywords: COVID-19; MIS-C; appendicitis; children; multisystem; pediatric.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
ROC curve of CRP when distinguishing MIS-C from AA cases.
Figure 2
Figure 2
ROC curve of MIS-C score when distinguishing MIS-C from AA cases.

Similar articles

Cited by

References

    1. Andina D., Belloni-Fortina A., Bodemer C., Bonifazi E., Chiriac A., Colmenero I., Diociaiuti A., El-Hachem M., Fertitta L., van Gysel D., et al. Skin manifestations of COVID-19 in children: Part 3. Clin. Exp. Dermatol. 2020;46:462–472. doi: 10.1111/ced.14483. - DOI - PMC - PubMed
    1. Lazova S., Dimitrova Y., Hristova D., Tzotcheva I., Velikova T. Cellular, Antibody and Cytokine Pathways in Children with Acute SARS-CoV-2 Infection and MIS-C—Can We Match the Puzzle? Antibodies. 2022;11:25. doi: 10.3390/antib11020025. - DOI - PMC - PubMed
    1. Al-Beltagi M., Saeed N.K., Bediwy A.S., El-Sawaf Y. Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications. World J. Gastroenterol. 2021;27:1716–1727. doi: 10.3748/wjg.v27.i16.1716. - DOI - PMC - PubMed
    1. Nikolopoulou G.B., Maltezou H.C. COVID-19 in Children: Where do we Stand? Arch. Med. Res. 2022;53:1–8. doi: 10.1016/j.arcmed.2021.07.002. - DOI - PMC - PubMed
    1. Rabaan A.A., Al-ahmed S.H., Mutair A.A., Alhumaid S. Immunopathogenesis and immunobiology of SARS-CoV-2. Le Infez. Med. 2021;2:167–180. - PubMed

Substances

Supplementary concepts